IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $224,805 | +19.6% | 10,500 | 0.0% | 0.09% | +6.8% |
| Q3 2022 | $188,000 | +86.1% | 10,500 | 0.0% | 0.09% | +87.2% |
| Q2 2022 | $101,000 | -42.9% | 10,500 | 0.0% | 0.05% | -37.3% |
| Q1 2022 | $177,000 | +0.6% | 10,500 | 0.0% | 0.08% | +7.1% |
| Q4 2021 | $176,000 | +2.9% | 10,500 | 0.0% | 0.07% | -10.3% |
| Q3 2021 | $171,000 | +159.1% | 10,500 | 0.0% | 0.08% | +160.0% |
| Q2 2021 | $66,000 | +1.5% | 10,500 | 0.0% | 0.03% | -37.5% |
| Q1 2021 | $65,000 | -5.8% | 10,500 | +5.0% | 0.05% | +29.7% |
| Q4 2020 | $69,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |